María Luisa de Francia Caballero

Ms. de Francia has been with PharmaMar and its predecessor Zeltia since 1988 holding various positions in the finance department, and becoming the Chief Financial Officer of Zeltia in 2000, and then for PharmaMar since the PharmaMar-Zeltia merger in 2015. Ms. de Francia holds an undergraduate degree in law, as well as a graduate degree in Business Administration from the Universidad Pontifical Comillas (ICADE) de Madrid. She also is a member of the Board of Directors for GENOMICA subsidiary.